MLC Medical LLC has established a collaboration with South Korea’s Hanlim Pharm. Co., Ltd. to introduce specialized hospital reversal agents to Georgia.

The partnership introduces two vital clinical counter-agents: BriTurn Inj. (Sugammadex Sodium) for rapid, complete reversal of rocuronium-induced neuromuscular block, and Hanlim Protamine Sulfate Inj. for urgent reversal of heparin-induced anticoagulation during and after surgery.

These therapies give anesthesiologists and surgical teams critical control over perioperative physiology, minimizing recovery times and enhancing operating room safety.

MLC Medical looks forward to a sustainable relationship with Hanlim Pharm that empowers local surgical units with rapid-acting reversal therapies.